TrialInternational immunopharmacology2021

Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome.

Abolghasem Allahyari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.